India: Trade Regulation & Practices

After a decade-long investigation into allegations of anti-competitive practices in Delhi's hospital sector, India's Competition Commission has delivered a landmark ruling on aftermarket abuse and excessive pricing. The case, which began with complaints about disposable syringe markups at Max Super Specialty Hospital, evolved into a comprehensive examination of pricing practices across 12 super specialty hospitals, ultimately establishing critical precedents for defining healthcare aftermarkets and applying

The India-Korea CEPA bilateral safeguard investigation on Non-phthalate Plasticizers raises a critical question: Can safeguard measures remain in force after the transition period expires?

The Competition Commission of India examines allegations against the Venkateshwara Hatcheries Group concerning potential abuse of dominant position and anti-competitive practices in India's commercial poultry sector. People for Animals claims the vertically integrated enterprise leverages significant market power across breeding, feed production, and distribution of layer hens and broiler chickens.

By way of order dated August 30, 2018, the CCI imposed a penalty of INR 9,64 06,682 on Geep Industries (India) Private limited (‘Geep') for being in a bilateral ancillary cartel with Panasonic (India).

The Competition Commission of India (CCI) notified the Competition Commission of India (Procedure in regard to the transaction of business relating to combinations) Amendment Regulations, 2018 on 9 October 2018 (Amendment Regulations).

It creates efficient and glowing atmosphere everywhere.

The Informant alleged that the Opposite Party ('OP') made available the Mumbai edition of 'The Times of India' in a combo offer with 'Mumbai Mirror' or 'The Economic Times' or 'Maharashtra Times' at a selling price of INR 7.

COMPAT has upheld order of CCI whereby it declined to order an investigation into the allegations of abuse of dominance by Vodafone India for levying exorbitant charges for international roaming plan.

The CCI directed the Director General to investigate Mahyco Monsanto Biotech (I) Limited, Monsanto Holdings Private Ltd., Monsanto Inc., U.S.A. and Maharashtra Hybrid Seeds Company Ltd.